Literature DB >> 28132571

The diagnosis and management of respiratory viral infections in cystic fibrosis.

William Flight1, Andrew Jones2,3.   

Abstract

INTRODUCTION: Respiratory viruses, such as those that cause influenza and the common cold, are a regular feature of life for the entire human population. Among people with CF, these viruses are associated with prolonged respiratory illness and show a clear association with pulmonary exacerbations which in turn are associated with lung function decline and risk of death. Human rhinovirus is the most commonly encountered respiratory viral pathogen in CF although adenovirus, bocavirus, coronavirus, influenza, parainfluenza, metapneumovirus and respiratory syncytial virus are all also responsible for infections in this population. Areas covered: This article reviews the epidemiology, clinical impact and therapeutic options for respiratory virus infection in both children and adults with CF. Expert commentary: The management of CF to date has largely focused on airway clearance strategies, nutritional support and aggressive antibacterial therapy. We highlight the significant role that respiratory viruses play in CF lung disease and argue that these pathogens represent an under-exploited target in the battle to control patients' symptoms and disease progression.

Entities:  

Keywords:  Anti-virals; cystic fibrosis; influenza; respiratory virus; rhinovirus

Mesh:

Year:  2017        PMID: 28132571     DOI: 10.1080/17476348.2017.1288102

Source DB:  PubMed          Journal:  Expert Rev Respir Med        ISSN: 1747-6348            Impact factor:   3.772


  8 in total

1.  UK circulating strains of human parainfluenza 3: an amplicon based next generation sequencing method and phylogenetic analysis.

Authors:  Anna Smielewska; Edward Emmott; Kyriaki Ranellou; Ashley Popay; Ian Goodfellow; Hamid Jalal
Journal:  Wellcome Open Res       Date:  2018-11-26

Review 2.  Elucidating the Interaction of CF Airway Epithelial Cells and Rhinovirus: Using the Host-Pathogen Relationship to Identify Future Therapeutic Strategies.

Authors:  Kak-Ming Ling; Luke W Garratt; Timo Lassmann; Stephen M Stick; Anthony Kicic
Journal:  Front Pharmacol       Date:  2018-11-07       Impact factor: 5.810

3.  Seasonal respiratory virus testing in management of adult cystic fibrosis patients.

Authors:  S Gohil; B Donaghy; D Tature; J Kowal; S Lea; F Y L Lai; S Range; J W Tang
Journal:  J Hosp Infect       Date:  2019-07-04       Impact factor: 3.926

Review 4.  Boosting Nitric Oxide in Stress and Respiratory Infection: Potential Relevance for Asthma and COVID-19.

Authors:  Thomas Ritz; Margot L Salsman; Danielle A Young; Alexander R Lippert; Dave A Khan; Annie T Ginty
Journal:  Brain Behav Immun Health       Date:  2021-04-05

5.  Identification of differentially expressed genes and their major pathways among the patient with COVID-19, cystic fibrosis, and chronic kidney disease.

Authors:  Golap Babu; Fahim Alam Nobel
Journal:  Inform Med Unlocked       Date:  2022-08-07

Review 6.  Exploring the Cystic Fibrosis Lung Microbiome: Making the Most of a Sticky Situation.

Authors:  Christina S Thornton; Nicole Acosta; Michael G Surette; Michael D Parkins
Journal:  J Pediatric Infect Dis Soc       Date:  2022-09-07       Impact factor: 5.235

7.  A Link Between a Common Mutation in CFTR and Impaired Innate and Adaptive Viral Defense.

Authors:  Emma Svedin; Renata Utorova; Michael H Hühn; Pär G Larsson; Virginia M Stone; Manasa Garimella; Katharina Lind; Thomas Hägglöf; Terezia Pincikova; Olli H Laitinen; Gerald M McInerney; Bob Scholte; Lena Hjelte; Mikael C I Karlsson; Malin Flodström-Tullberg
Journal:  J Infect Dis       Date:  2017-12-05       Impact factor: 5.226

8.  Course of Illness after Viral Infection in Indian Children with Cystic Fibrosis.

Authors:  Krishna Mohan Gulla; Arvind Balaji; Aparna Mukherjee; Kana Ram Jat; Jhuma Sankar; Rakesh Lodha; Sushil K Kabra
Journal:  J Trop Pediatr       Date:  2019-04-01       Impact factor: 1.165

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.